Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LMB-9 immunotoxin in patients with advanced pancreatic, esophageal, gastric, or colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• LMB-9 immunotoxin

Snippet

Sponsor: University Hospital Freiburg | Conditions: Colorectal Cancer, Esophageal Cancer | Phase 1 | Status: UNKNOWN